Alliance Pharma Share Price (APH)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Alliance Pharma	LSE:APH	London	Ordinary Share	GB0031030819	ORD 1P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+0.60p	+0.96%	63.40p	574,023	16:35:03

Bid Price		Offer Price	High Price	Low Price	Open Price
63.00p		63.60p	63.60p	60.00p	60.00p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	103.32	28.37	6.10	10.4	326.6

Related Shares
AstraZeneca (AZN), GlaxoSmithKline (GSK), Venn Life (VENN), Port Erin (PEBI)

Alliance Pharma (APH) Latest News

Alliance Pharma News

Date	Time	Source	Headline
12/11/2018	16:41	ALNC	DIRECTOR DEALINGS: Alliance Pharma Non-Exec Sells GBP770,000 In Shares
12/11/2018	15:51	UKREG	Alliance Pharma PLC Director Share Dealing
05/10/2018	09:25	UKREG	Alliance Pharma PLC Grant of Options to Directors
02/10/2018	07:36	ALNC	Alliance Pharma Hails "Significant Milestone" As Xonvea Launches In UK
02/10/2018	06:16	ALNCF	Alliance News Flash Headline
02/10/2018	06:00	UKREG	Alliance Pharma PLC Xonvea launch in the UK
19/9/2018	09:00	ALNC	Alliance Pharma Hikes Interim Payout As Underlying Profit, Sales Rise
19/9/2018	06:01	UKREG	Alliance Pharma PLC Interim results
16/8/2018	06:01	UKREG	Alliance Pharma PLC Notice of Results
10/8/2018	09:00	UKREG	Alliance Pharma PLC Total Voting Rights

More Alliance Pharma News

Alliance Pharma Takeover Rumours

Alliance Pharma (APH) Share Charts

1 Year Alliance Pharma Chart

1 Month Alliance Pharma Chart

Intraday Alliance Pharma Chart

Alliance Pharma (APH) Discussions and Chat

Alliance Pharma Forums and Chat

Date	Time	Title	Posts
16/11/2018	17:12	Alliance Pharma pays Dividends	1,258
21/8/2018	16:36	A Canadian Stock Worth Watching	1
11/6/2018	09:21	Unexpected	-
07/11/2016	15:35	Alliance Pharma plc	1
15/7/2013	09:15	ALLIANCE PHARMA – 2005 Strong Riser	611

Add a New Thread

Alliance Pharma (APH) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2018-11-16 17:05:15	63.40	1,424	902.77	O
2018-11-16 16:54:14	63.26	18,634	11,787.68	O
2018-11-16 16:52:26	63.35	56,123	35,552.24	O
2018-11-16 16:51:53	62.00	8,000	4,960.00	O
2018-11-16 16:51:47	61.96	9,305	5,765.28	O

View all Alliance Pharma trades in real-time

Alliance Pharma (APH) Top Chat Posts

Date	Subject
16/11/2018 08:20	Alliance Pharma Daily Update: Alliance Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker APH. The last closing price for Alliance Pharma was 62.80p. Alliance Pharma has a 4 week average price of 60p and a 12 week average price of 60p. The 1 year high share price is 102.50p while the 1 year low share price is currently 58p. There are currently 515,127,294 shares in issue and the average daily traded volume is 1,018,561 shares. The market capitalisation of Alliance Pharma is £326,590,704.40. Read Full Thread Reply
16/11/2018 07:45	winnings1: I do not think it likely that the share price will go down much further from where it is just now (62p), indeed I think it likely that we may see a rise to region 70p-75p over the coming weeks, assuming the global stock markets are to stabilize. Read Full Thread Follow Reply
15/11/2018 15:43	winnings1: One Director selling a smallish portion of his large holding does not amount to the Board selling out. We need to remember that Directors have a home to keep up or a new larger home to move into, a family to look after, school fees to pay etc., so nothing ominous about a Director s selling a portion of his shares to raise cash for his needs. The share price today is much below where it should be. The fundamentals are sound and solid and point in the direction of 80p+ as fair value. The markets in general are wobbly and much of that is to be blamed on Trump and his threats of trade wars. Nobody benefits form trade wars, least of all the American consumers who will have to pay more for their imported goods. America can not compete with China on prices, not even by doubling or trebling import levies. The only ways to compete with China on prices is to decimate US labour costs. Try that one Trump! Read Full Thread Follow Reply
29/10/2018 10:44	winnings1: Dround87 - If earnings were rising fast then the share price would be region 150p. Defensive stock because of steady rising earnings in a continuing (permanent) growth market (medicines). Read Full Thread Follow Reply
28/10/2018 19:10	winnings1: I consider APH a defensive stock, the share price may wobble a little but won't crash in these turbulent times, indeed may even rise when markets are in sharp falls. I hold long term. Read Full Thread Follow Reply
18/10/2018 15:36	cisk: Livingbridge aren’t even a major shareholder, there has been no RNS re their holding, I don’t think they were even over 3% and I’m sorry I’m not going to sit through their webinar to find out what they said. For those that are concerned, take a look at Livingbridge’s top 10 holdings - nothing much to write home about. And they mirror their benchmark and I wouldn’t say their performance is spectacular. So I just don’t see the performance of an average fund impacting the share price to that extent. So personally I care not a jot what this fund does. I do care about upcoming launches and the pending good news flow coming from the company, and Nizoral sales getting going and feeding through to the bottom line. Really the share price got ahead of itself this year, it’s probably oversold now but it’s an opportunity to top up, if you feel like doing so in the current market. Alliance has grown steadily, and through deals etc it’s not as reliant on a single product as it once was. Read Full Thread Follow Reply
18/10/2018 11:13	winnings1: Remarkable how low the share price of APH has gone (65p-66p today). In the current uncertain times (political and financial) the shares of APH should be at a premium as the Company operates in recession proof territory, Demand for medicines will continue to go up, whatever the state of the global economy. Read Full Thread Follow Reply
11/10/2018 17:30	tryone2: Perhaps it’s time to look why the sudden drop in share price since July ? Read Full Thread Follow Reply
03/10/2018 13:14	winnings1: Nice Article in The Times about APH's newly licensed anti-sickness drug, should bode b well for a good start with sales. Share price, already up nicely, should harden from hereon. Read Full Thread Follow Reply
27/9/2018 12:24	winnings1: I personally think that the £2.5 million write-off in connection with the failed Chinese trading-arrangement for baby-nutrition/milk is the main culprit behind the share price fall. Read Full Thread Follow Reply
24/7/2017 09:24	arf dysg: I notice that the International Misery Fund said that we're screwed, blued and tattooed. Putting it in slightly more formal language, the predictions for growth in the USA and the UK have gone down a little. Perhaps that's why everyone's taking drugs as if there's no tomorrow, so the APH share price has gone up. Read Full Thread Follow Reply

Alliance Pharma share price data is direct from the London Stock Exchange

add chat code

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:32 V: D:20181117 04:24:10